Enlivex Therapeutics
ENLV
ENLV
21 hedge funds and large institutions have $1.32M invested in Enlivex Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.
Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
6
Closed
1
Calls
$1.21M
Puts
$207K
Net Calls
+$1.01M
Net Calls Change
-$848K
Top Buyers
Top Sellers
1 |
1
Wells Fargo
San Francisco,
California
|
$46.3K |
2 |
2
Renaissance Technologies
New York
|
$213K |
3 |
3
Morgan Stanley
New York
|
$160K |
4 |
4
Goldman Sachs
New York
|
$74.5K |
5 |
SIGI
5
Susquehanna International Group (Ireland)
Dublin,
Ireland
|
$72.1K |